amoxicillin

(redirected from Moxatag)
Also found in: Dictionary, Thesaurus.
Related to Moxatag: Dispermox

amoxicillin

 [ah-moks″ĭ-sil´in]
an antibiotic that is a penicillin analogue similar in action to ampicillin but more efficiently absorbed from the gastrointestinal tract and therefore requiring less frequent dosage and not as likely to cause diarrhea.

a·mox·i·cil·lin

(ă-mok'si-sil'in),
A semisynthetic penicillin antibiotic with an antimicrobial spectrum similar to that of ampicillin.

amoxicillin

/amox·i·cil·lin/ (ah-mok″sĭ-sil´in) a semisynthetic derivative of ampicillin effective against a broad spectrum of gram-positive and gram-negative bacteria.

amoxicillin

(ə-mŏk′sĭ-sĭl′ĭn)
n.
A semisynthetic penicillin, C16H19N3O5S, having an antibacterial spectrum of action similar to that of ampicillin.

amoxicillin

[əmok′səsil′in]
a beta-lactam semisynthetic oral penicillin antibiotic.
indication It is prescribed in the treatment of infections caused by a susceptible gram-negative or gram-positive bacteria.
contraindication Known hypersensitivity to any penicillin prohibits its use.
adverse effects Among the most serious adverse reactions are anaphylaxis, nausea, and diarrhea. Allergic reactions and rashes are common.

amoxicillin

Infectious disease A broad-spectrum semisynthetic penicillin with activity similar to that of ampicillin

amoxicillin

Amoxycillin, an AMPICILLIN-like penicillin antibiotic, effective in TYPHOID and many other infections. Brand names are Amoxil and Galenamox. Compounded with lansoprazol and clarithromycin it is marketed as Heliclear.

amoxicillin

penicillin antibiotic of similar action to ampicillin; usually administered as 250 mg by mouth every 8 hours (125 mg every 8 hours for a child) for soft-tissue infections

a·mox·i·cil·lin

(ă-mok'si-sil'in)
A semisynthetic penicillin antibiotic with an antimicrobial spectrum similar to that of ampicillin.

amoxicillin, amoxycillin

an aminopenicillin, similar in action to ampicillin and susceptible to β-lactamase, but more efficiently absorbed from the gastrointestinal tract and with a longer duration of action.

amoxicillin-clavulanic acid
addition of clavulanic acid widens the spectrum of activity and renders amoxicillin resistant to β-lactamase. A widely used antibiotic in dogs and cats.
References in periodicals archive ?
In this randomized, double-blind, double-dummy, parallel-group, non-inferiority trial, 775-mg Moxatag tablets were administered once daily for 10 days, compared with a regimen of 250 mg penicillin administered 4 times daily (1 g total dose) for 10 days.
Moxatag (extended-release amoxicillin) Tablets, 775mg, is a once-a-day extended-release formulation of amoxicillin for oral administration consisting of three components: one immediate-release component and two delayed-release components.
Comment: Safety and efficacy are based on a clinical trial of 608 adult and adolescent patients aged 12 years and older treated with Moxatag 775 mg once daily for 10 days or penicillin VK 250 mg q.
MOXATAG, and PULSYS are MiddleBrook's trademarks and have been registered in the U.
MOXATAG utilizes PULSYS technology to deliver drug at set intervals over a 24 hour period, whereas other amoxicillin products require multiple times daily dosing.
Jay Grobowsky, president and CEO of DoctorDirectory, said, "We look forward to providing a promotional boost for MOXATAG through IncreaseRx[R] and providing increased access to MOXATAG samples and information to physicians nationwide.
the Company's chairman of the board, said, "On behalf of the Company and the entire board of directors, I'd like to thank John for taking on this challenge and building MOXATAG to its current level of over 6,500 prescriptions per week during very tough economic times.
We're in the process of securing national retail distribution for Moxatag across the food, drug and mass channels, which includes independent and chain retailers," Thievon continued.
We are pleased to partner with DoctorDirectory to promote MOXATAG, the only FDA-approved once-daily amoxicillin.
The Company currently markets the Keflex brand of cephalexin and has received regulatory approval for Moxatag -- the first and only once-daily amoxicillin product approved for marketing in the U.
Pulsys, Moxatag and Keflex are our trademarks and have been registered in the U.
We will begin recruiting our national field force shortly, and the entire MiddleBrook team is energized and focused on the execution of our plan to successfully launch our first proprietary Pulsys(R) product, Moxatag -- the first and only FDA-approved once-daily amoxicillin -- in first quarter 2009," Thievon continued.